Molecular mechanism of ATP-dependent solute transport by multidrug resistance-associated protein 1

Xiu-bao Chang1

  • 1Mayo Clinic College of Medicine, Mayo Clinic Arizona, Scottsdale, AZ, USA. xbchang@mayo.edu

Insights

Multidrug resistance (MDR) in cancer hinders chemotherapy effectiveness. This review details the molecular mechanism of ATP-dependent solute transport by the MRP1 transporter, a key factor in MDR.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Cancer is a significant global health issue, with chemotherapy being a primary treatment for metastatic cancers.
  • Cellular multidrug resistance (MDR) frequently leads to treatment failure by preventing effective cancer cell killing.
  • ATP-binding cassette transporters, including MRP1, are implicated in acquired MDR through their drug efflux capabilities.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying ATP-dependent solute transport mediated by the Multidrug Resistance-Associated Protein 1 (MRP1).
  • To provide a comprehensive review of MRP1's role in conferring cellular multidrug resistance.

Main Methods:

  • Literature review focusing on molecular mechanisms of MRP1.
  • Analysis of studies detailing ATP-dependent solute transport processes.
  • Examination of MRP1's interaction with anticancer drugs.

Main Results:

  • MRP1 utilizes ATP hydrolysis to actively transport a diverse range of anticancer drugs out of cells.
  • Over-expression of MRP1 is a significant contributor to acquired cellular multidrug resistance.
  • Understanding MRP1's transport mechanism is crucial for overcoming chemotherapy resistance.

Conclusions:

  • MRP1-mediated drug efflux is a critical mechanism driving chemotherapy resistance in cancer.
  • Targeting MRP1 function may offer strategies to improve chemotherapeutic efficacy.
  • Further research into MRP1's molecular transport is warranted for clinical applications.

Related Concept Videos

Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active Transport01:14

Active Transport

Active transport is a critical biological process that allows cells to move solutes against an electrochemical gradient. This process requires direct energy input and is characterized by its selectivity, saturability, and susceptibility to competitive inhibition.
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
Membrane Transporters01:31

Membrane Transporters

Transporters are essential membrane transport proteins with functions related to cell nutrition, homeostasis, communication, etc. Approximately 7% of all genes in the human genome code for transporters or transporter-related proteins.
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
ATP Driven Pumps I: An Overview01:27

ATP Driven Pumps I: An Overview

ATP-driven pumps, also known as transport ATPases, are integral membrane proteins. They have binding sites for ATP located on the membrane's cytosolic side and the ion-conducting domain in the transmembrane region. These pumps use the free energy released from ATP hydrolysis to move the solutes across cell membranes against an electrochemical gradient.
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and are...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...